Literature DB >> 6832386

Role of splanchnic venous system in overall cardiovascular homeostasis.

C V Greenway.   

Abstract

A blood reservoir is an organ or region containing a significant portion of the blood volume that can be mobilized by the sympathetic nervous system to subserve overall cardiovascular homeostasis. To be effective, the reservoir must be as insensitive as possible to the passive effects of changes in flows or external pressures. Evidence is presented that the splanchnic venous bed fulfills these criteria. Hepatic venous resistance maintains portal pressure and intrinsic hepatic arterial mechanisms maintain total hepatic flow. These mechanisms minimize passive effects of portal flow changes on splanchnic blood volume, whereas enclosure of the liver in the peritoneal cavity minimizes effects of external pressures. Up to 27% of total blood volume can be mobilized from the splanchnic venous bed by sympathetic stimulation. Maintenance of cardiac preload depends on the ability of the central nervous system to control venous compliance and hence to redistribute blood volume between peripheral organs and the cardiopulmonary compartment. Three examples of the role of the splanchnic blood reservoir in overall homeostasis are discussed: hemorrhage, splanchnic nerve stimulation, and responses to epinephrine. Reflex and central control of the splanchnic blood reservoir are discussed but available information is fragmentary.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6832386

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  28 in total

Review 1.  Hepatic haemodynamics as related to blood flow through gut, spleen, and pancreas.

Authors:  G A Charbon; M F Anderson
Journal:  Gut       Date:  1989-02       Impact factor: 23.059

2.  Comparison of the frequency dependence of venous and arterial responses to sympathetic nerve stimulation in guinea-pigs.

Authors:  O D Hottenstein; D L Kreulen
Journal:  J Physiol       Date:  1987-03       Impact factor: 5.182

3.  Stimulation of glycogenolysis by adenine nucleotides in the perfused rat liver.

Authors:  D B Buxton; S M Robertson; M S Olson
Journal:  Biochem J       Date:  1986-08-01       Impact factor: 3.857

4.  5-HT causes splanchnic venodilation.

Authors:  Bridget M Seitz; Hakan S Orer; Teresa Krieger-Burke; Emma S Darios; Janice M Thompson; Gregory D Fink; Stephanie W Watts
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-06-16       Impact factor: 4.733

5.  Involvement of the sympathetic nervous system in the cardiovascular effects of ACTH-(1-24) during hemorrhagic shock in rats.

Authors:  S Guarini; W Ferrari; A Bertolini
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-05       Impact factor: 3.000

6.  Burst patterning of hypothalamic paraventricular nucleus-driven sympathetic nerve activity in ANG II-salt hypertension.

Authors:  Walter W Holbein; Megan B Blackburn; Mary Ann Andrade; Glenn M Toney
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-11-22       Impact factor: 4.733

Review 7.  Right Heart Failure and Cardiorenal Syndrome.

Authors:  Thida Tabucanon; Wai Hong Wilson Tang
Journal:  Cardiol Clin       Date:  2020-03-02       Impact factor: 2.213

8.  Vascular impairment of adenosinergic system in hypertension: increased adenosine bioavailability and differential distribution of adenosine receptors and nucleoside transporters.

Authors:  Ana Sousa-Oliveira; Ana Brandão; Martin Vojtek; Salomé Gonçalves-Monteiro; Joana B Sousa; Carmen Diniz
Journal:  Histochem Cell Biol       Date:  2018-10-24       Impact factor: 4.304

9.  Stimulation of hepatic glycogenolysis by phorbol 12-myristate 13-acetate.

Authors:  T B Patel
Journal:  Biochem J       Date:  1987-01-15       Impact factor: 3.857

10.  Increased superoxide levels in ganglia and sympathoexcitation are involved in sarafotoxin 6c-induced hypertension.

Authors:  Melissa Li; Xiaoling Dai; Stephanie Watts; David Kreulen; Gregory Fink
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-09-03       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.